Advertisement Caraco wins summary judgment on generic Ultracet - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Caraco wins summary judgment on generic Ultracet

Caraco Pharmaceutical Laboratories has confirmed that the District Court of New Jersey has granted the company's motion for summary judgment that the claims of US patent that Ortho-McNeil Pharmaceutical asserted against Caraco are invalid.

Caraco’s tramadol with acetaminophen product is a generic version of Ortho-McNeil’s Ultracet. The company commenced shipment of tramadol with acetaminophen following the FDA’s approval to manufacture, market and distribute the generic product on December 19, 2005, and it has remained on the market since that time.